BWI: GVK Biosciences Strengthens Focus on “Development” Services

Press release from Business Wire India
Source: GVK Biosciences Private Limited
Wednesday, December 03, 2008 11:30 AM IST (06:00 AM GMT)
Editors: General: People; Business: Accounting & management consultancy services, Business services, Healthcare, biotechnology & pharmaceutical; Healthcare
Release no: 18652
--------------------------------------------------
GVK Biosciences Strengthens Focus on "Development" Services
Appoints Dr. Shoibal Mukherjee as Senior Vice President - Clinical Development

Hyderabad, Andhra Pradesh, India, Wednesday, December 03, 2008 -- (Business Wire India) -- GVK Biosciences Private Limited (GVK BIO), one of Asia's leading CROs, today announced the appointment of Dr. Shoibal Mukherjee to the position of Senior Vice President - Clinical Development.

"Expanding and enriching our leadership team is critical for GVK BIO's vision of being a leading life-sciences services company," said D S Brar, Chairman, GVK BIO. "Dr.Shoibal Mukherjee has extensive experience in managing global clinical trials and will play a pivotal role in the growth of the company's 'Development' services."

Prior to joining GVK BIO, Dr. Mukherjee served in Ranbaxy and Pfizer in senior positions. Dr. Mukherjee graduated as a physician and is an MD and DM in Pharmacology. Professionally trained in clinical & pharmaceutical medicine, Dr. Mukherjee has vast experience in managing Clinical Trials, Medical Affairs, Clinical Data Management, and Clinical Pharmacology. Dr. Mukherjee has authored several research papers and is a visiting faculty for established universities and medical institutions. Dr. Mukherjee is the Founding President of the Indian Society for Clinical Research and a member of several committees.

Dr. Shoibal Mukherjee is the most recent in a series of senior-level appointments at GVK BIO. Earlier this year, GVK BIO had recruited Dr. Sailendra Goswami as Vice President for Clinical Pharmacology. Dr. Goswami previously worked as CEO of Veeda Clinical Research Pvt. Ltd. and played a key role right from its inception.

GVK BIO has also strengthened its international Clinical Research Business Development team by recruiting William Harel as Vice President - Business Development, in the West Coast of USA. A PhD in Immunology, William is responsible for developing the business of Clinical Research in the US and globally. William has over 20 years of experience in various companies including Chiron Corporation, AAI Pharma and Neeman Medical International.

In addition to its well established services in Discovery Research and Informatics, GVK BIO offers Clinical Development services that span Special population studies to Phase II - IV clinical trials, Data Management, Biostatistics, Medical Writing, Pharmacovigilance, Bioequivalence studies, and Bioanalytical services.

"I am delighted to join GVK Biosciences and look forward to making GVK BIO a global clinical development service provider" said Dr.Shoibal Mukherjee on his appointment.

About GVK BIO

GVK Biosciences (www.gvkbio.com), Asia's leading Contract Research Organization, delivers integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug Discovery and Development process of its customers through science and innovation. Currently the company has more than 1,300 employees spread across facilities in Hyderabad, Chennai, Mumbai and Gurgaon.

To view the photograph, please click on the link given below:

Dr.Shoibal Mukherjee

For picture(s)/data to illustrate this release click below:

http://www.BusinessWireIndia.com/attachments/Pic_1(6).BMP
Pic_1(6).BMP



CONTACT DETAILS
Sharada Alvakonda, GVK Biosciences Private Limited, +91 (040) 66929998/9, +91 9989233415, sharada@gvkbio.com

KEYWORDS
PEOPLE, CONSULTANCY SERVICES, BUSINESS SERVICES, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com